Eiger Biopharmaceuticals Inc Revenue per Employee (EIGR), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Eiger Biopharmaceuticals Inc   (NASDAQ: EIGR)
 

Eiger Biopharmaceuticals Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 41.06% in the fourth quarter 2023, year on year to cumulative value of $16 million, Eiger Biopharmaceuticals Inc 's revenue per employee grew on a trailing twelve months basis to $ 262,883, this marks a new company high.
Within the Healthcare sector Employees of 359 other companies have achieved higher revenue per employee. While Eiger Biopharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 2816. Eiger Biopharmaceuticals Inc has 60 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EIGR Revenue per Employee (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Revenue Change 41.06 % -20.25 % 13.49 % 54.06 % -19.76 %
Sales per Employee (TTM) $ 262,883 244,433 258,017 248,817 224,733
EIGR's Total Ranking # 2816 # 0 # 0 # 0 # 0
Seq. Revenue Change 18.51 % -30.89 % 12.75 % 52.74 % -33 %

EIGR Company Profile >> Back to EIGR Efficiency Comparisons >> Compare EIGR Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 43
Healthcare Sector # 360
Overall Market # 2816

Revenue per Employee Statistics
High Average Low
$ 262,883 $ 231,398 $ 186,150
(Dec 31 2023)   (Mar 31 2022)



Financial Statements
Eiger Biopharmaceuticals Inc 's Revenue MRQ $ 4 Millions Visit EIGR's Income Statement
Eiger Biopharmaceuticals Inc 's Revenues TTM $ 16 Millions Visit EIGR's aggregate revenue growth
What are EIGR's Sales? Visit EIGR's Sales by Segment




Other Ratios
Eiger Biopharmaceuticals Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
EIGR's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for EIGR's Competitors
Revenue per Employee for EIGR's Suppliers
Revenue per Employee for EIGR's Customers

You may also want to know
EIGR's Sales Growth Rates EIGR's Pe Price to earnings ratio EIGR's Receivables Turnover Ratio EIGR's Stock Quote
EIGR's Net Income Growth Rates EIGR's Ps Price to Sales ratio EIGR's Sales per Employee EIGR's Asset Turnover Ratio
EIGR's Net Margin EIGR's Pb Price to Book ratio EIGR's Financial Strength Ratios EIGR's Dividend Payout Ratio
Date modified: 2026-09-08T15:11:13+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2023, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2023Number of Employees Dec 31 2023
Maxcyte inc   453,714.29 $ 41.288  Million 91 
Zevra Therapeutics Inc   450,180.33 $ 27.461  Million 61 
Elanco Animal Health Incorporated  446,161.62 $ 4,417.000  Million 9,900 
Revance Therapeutics Inc   438,277.15 $ 234.040  Million 534 
Zimmer Biomet Holdings Inc   434,952.94 $ 7,394.200  Million 17,000 
Bausch Health Companies Inc   431,379.31 $ 8,757.000  Million 20,300 
Sight Sciences Inc   431,048.39 $ 80.175  Million 186 
Blueprint Medicines Corporation  428,487.97 $ 249.380  Million 582 
Aclaris Therapeutics Inc   428,068.49 $ 31.249  Million 73 
Cumberland Pharmaceuticals Inc   425,295.77 $ 39.553  Million 93 
23andme Holding Co  423,920.96 $ 246.722  Million 582 
Olink Holding Ab publ   423,652.50 $ 169.461  Million 400 
Shl Telemedicine Ltd  422,777.78 $ 57.075  Million 135 
Haemonetics Corporation  420,076.41 $ 1,269.891  Million 3,023 
Outset Medical Inc   419,354.84 $ 130.000  Million 310 
Inogen Inc   419,203.19 $ 315.660  Million 753 
Merus N v   418,542.86 $ 43.947  Million 105 
Intuitive Surgical Inc   418,512.43 $ 7,123.500  Million 17,021 
Nanobiotix S a   418,060.21 $ 40.552  Million 97 
Curis Inc   417,625.00 $ 10.023  Million 24 
Nutriband Inc   417,060.20 $ 2.085  Million 5 
Nrc Health  416,190.48 $ 148.580  Million 357 
Treace Medical Concepts Inc   415,817.78 $ 187.118  Million 450 
Cryo cell International Inc   412,417.04 $ 31.344  Million 76 
Pacific Biosciences Of California Inc   411,917.53 $ 199.780  Million 485 
Sensus Healthcare Inc   406,750.00 $ 24.405  Million 60 
Travere Therapeutics Inc   400,088.53 $ 198.844  Million 497 
Adma Biologics Inc   397,464.91 $ 257.160  Million 647 
Mimedx Group Inc   396,889.85 $ 320.687  Million 808 
Esperion Therapeutics Inc   395,693.88 $ 116.334  Million 294 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.